Vipawee S Chat, Christoph T Ellebrecht, Paige Kingston, George Gondo, Stacie Bell, Kelly M Cordoro, Seemal R Desai, Kristina C Duffin, Steven R Feldman, Amit Garg, Joel M Gelfand, Dafna Gladman, Lawrence J Green, Johann Gudjonsson, George Han, Jason E Hawkes, Leon Kircik, John Koo, Richard Langley, Mark Lebwohl, G Michael Lewitt, Wilson Liao, George Martin, Ana-Maria Orbai, Soumya M Reddy, Veronica Richardson, Christopher T Ritchlin, Sergio Schwartzman, Evan L Siegel, Abby S Van Voorhees, Elizabeth B Wallace, Jeffrey M Weinberg, Kevin L Winthrop, Paul Yamauchi, April W Armstrong
BACKGROUND: For psoriatic patients who need to receive nonlive or live vaccines, evidence-based recommendations are needed regarding whether to pause or continue systemic therapies for psoriasis and/or psoriatic arthritis. OBJECTIVE: To evaluate literature regarding vaccine efficacy and safety and to generate consensus-based recommendations for adults receiving systemic therapies for psoriasis and/or psoriatic arthritis receiving nonlive or live vaccines. METHODS: Using a modified Delphi process, 22 consensus statements were developed by the National Psoriasis Foundation Medical Board and COVID-19 Task Force, and infectious disease experts...
February 7, 2024: Journal of the American Academy of Dermatology